Cadila Healthcare reports 32% rise in Q2 consolidated net profit

14 Nov 2017 Evaluate

Cadila Healthcare has reported results for second quarter ended September 30, 2017.

The company has reported around 12-fold jump in its net profit at Rs 449.80 crore for the quarter under review as compared to Rs 38.10 crore for the same quarter in the previous year. Also, total income of the company jumped over 2-fold to Rs 1805.70 crore for Q2FY18 as compared Rs 823.60 crore for the corresponding quarter previous year. 

On the consolidated basis, the company has reported 32.48% rise in its net profit after taxes , non-controlling interest and Share of Profits of Joint Ventures at Rs 503.30 crore for the quarter ended September 30, 2017 as compared to Rs 379.90 crore for the same quarter in the previous year. The total income of the company increased by 34.17% at Rs 3256.50 crore for quarter under review as compared to Rs 2427.10 crore for the quarter ended September 30, 2016.


Zydus Lifesciences Share Price

924.35 -7.10 (-0.76%)
08-Dec-2025 15:48 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1790.05
Dr. Reddys Lab 1272.70
Cipla 1498.90
Zydus Lifesciences 924.35
Lupin 2061.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×